164 related articles for article (PubMed ID: 37841278)
1. Case Report: Complete pathological remission of human chorionic gonadotrophin-producing gallbladder carcinoma with multiple liver metastases after treatment with chemotherapy plus an immune checkpoint inhibitor.
Wang Q; Mu Y; Ji S; Liu Y; Lou Y; Wei S; Dong X; Zhang B
Front Immunol; 2023; 14():1173520. PubMed ID: 37841278
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Durable Complete Response After Combined Immunotherapy Following Resection of Primary Tumor in a Gallbladder Cancer Patient With Distant Metastatic Lymph Nodes of Favorable Immune-Microenvironment.
Yi B; Zhao Z; Dong H; Yuan L; Wu Y; Xu Y; Jiang X; Sun C; Wu D; Xiao Y
Front Immunol; 2022; 13():820566. PubMed ID: 35242133
[TBL] [Abstract][Full Text] [Related]
3. [Gallbladder cancer with elevated serum α-fetoprotein, α-fetoprotein-L3, and human chorionic gonadotropin levels].
Goto A; Ishimine Y; Hirata T; Naito T; Yabana T; Adachi T; Kondo Y; Kasai K
Gan To Kagaku Ryoho; 2014 Aug; 41(8):1021-5. PubMed ID: 25132038
[TBL] [Abstract][Full Text] [Related]
4. Gallbladder carcinoma producing human chorionic gonadotropin.
Fukuda T; Ohnishi Y
Am J Gastroenterol; 1990 Oct; 85(10):1403-6. PubMed ID: 2220737
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer.
Zhang S; Nie J; Tai S; Zheng T
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38123314
[TBL] [Abstract][Full Text] [Related]
6. Elevated human chorionic gonadotrophin without pregnancy: A case of gallbladder carcinoma.
Leostic A; Tran PL; Fagot H; Boukerrou M
J Gynecol Obstet Hum Reprod; 2018 Mar; 47(3):141-143. PubMed ID: 29292237
[TBL] [Abstract][Full Text] [Related]
7. Differential treatment responses to immune checkpoint inhibitor (ICI) therapy in a case of multiple primary malignancies: the programmed death ligand-1 (PD-L1) negative ureteral and lung metastasis from a clear cell renal cell carcinoma appearing after robotic-assisted partial nephrectomy progressed after ICI therapy, while synchronous PD-L1-positive primary lung squamous cell carcinoma responded very well to ICI therapy: a case report.
Urushibara M; Ishizaka K; Matsutani N; Takahashi M; Nagata M; Okumura T; Matsumoto Y; Tatsuoka S; Nenohi T; Amemiya T; Shimizu Y; Shirakawa T; Kato D
World J Surg Oncol; 2023 Feb; 21(1):37. PubMed ID: 36747242
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine gallbladder cancer treated with cisplatin plus irinotecan - a case report].
Inoue D; Ozaka M; Muramatsu Y; Yamada I; Matsuyama M; Kanda H; Ishii H
Gan To Kagaku Ryoho; 2014 Jun; 41(6):765-7. PubMed ID: 25129091
[TBL] [Abstract][Full Text] [Related]
9. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
10. [Resection of Initially Unresectable Gallbladder Cancer with Multiple Liver Metastases after Chemotherapy with Gemcitabine plus Cisplatin].
Ajiki T; Matsumoto T; Shinozaki K; Murakami S; Kinoshita H; Goto T; Asari S; Toyama H; Kido M; Fukumoto T; Ku Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1500-2. PubMed ID: 26805076
[TBL] [Abstract][Full Text] [Related]
11. CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer.
Cao L; Bridle KR; Shrestha R; Prithviraj P; Crawford DHG; Jayachandran A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163489
[TBL] [Abstract][Full Text] [Related]
12. Gallbladder adenocarcinoma with human chorionic gonadotropin: a case report and review of literature.
Sato S; Ishii M; Fujihira T; Ito E; Ohtani Y
Diagn Pathol; 2010 Jul; 5():46. PubMed ID: 20594358
[TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Analysis Identifies Liver Metastases as Negative Predictive Factor for Immune Checkpoint Inhibitors Treatment Outcome.
Chen XJ; Ren A; Zheng L; Zheng ED; Jiang T
Front Immunol; 2021; 12():651086. PubMed ID: 34248939
[TBL] [Abstract][Full Text] [Related]
14. Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring
Wen L; Chen Z; Ji X; Fong WP; Shao Q; Ren C; Cai Y; Li B; Yuan Y; Wang D; Li Y
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793867
[TBL] [Abstract][Full Text] [Related]
15. Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non-small cell lung cancer negative for EGFR mutation and ALK fusion.
Sakai H; Takeda M; Sakai K; Nakamura Y; Ito A; Hayashi H; Tanaka K; Nishio K; Nakagawa K
Lung Cancer; 2019 Jan; 127():59-65. PubMed ID: 30642552
[TBL] [Abstract][Full Text] [Related]
16. Benefits of combination therapy with immune checkpoint inhibitors and predictive role of tumour mutation burden in hepatocellular carcinoma: A systematic review and meta-analysis.
Zheng J; Shao M; Yang W; Ren J; Chen X; Yang H
Int Immunopharmacol; 2022 Nov; 112():109244. PubMed ID: 36126410
[TBL] [Abstract][Full Text] [Related]
17. Successful Treatment of Metastatic Gallbladder Carcinoma with a High Tumor Mutational Burden Using Pembrolizumab.
Uehara S; Naganuma A; Furuichi N; Furusawa A; Kaburagi T; Naruse H; Tomaru S; Sano N; Suzuki Y; Masuda T; Hoshino T; Yasuoka H; Tanaka Y; Saito S; Hatanaka T; Kakizaki S
Intern Med; 2023 Nov; 62(21):3151-3156. PubMed ID: 36927965
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Successful Curative Resection Following Downsizing Chemotherapy in Initially Unresectable Locally Advanced Gallbladder Carcinoma].
Shinmura K; Kaiho T; Yanagisawa S; Okamoto R; Nishimura M; Kobayashi S; Okaniwa A; Mun Y; Tsuchiya S; Chiba R
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1726-8. PubMed ID: 26805152
[TBL] [Abstract][Full Text] [Related]
19. Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report.
Zhong L; Liu X; Li Z; Zhang X; Wang Y; Peng W
Front Oncol; 2021; 11():783158. PubMed ID: 35096582
[TBL] [Abstract][Full Text] [Related]
20. Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer.
Kawachi H; Yamada T; Tamiya M; Negi Y; Goto Y; Nakao A; Shiotsu S; Tanimura K; Takeda T; Okada A; Harada T; Date K; Chihara Y; Hasegawa I; Tamiya N; Ishida M; Katayama Y; Morimoto K; Iwasaku M; Tokuda S; Kijima T; Takayama K
JAMA Netw Open; 2023 Jul; 6(7):e2322915. PubMed ID: 37432682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
